1.How to make the best strategy to manage thromboembolism in ovarian cancer?.
Myong Cheol LIM ; Sang Yoon PARK
Journal of Gynecologic Oncology 2012;23(2):78-79
No abstract available.
Thromboembolism
2.Management of Venous Thromboembolism.
Journal of the Korean Society for Vascular Surgery 2009;25(1):82-85
No abstract available.
Venous Thromboembolism
3.JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism.
Blood Research 2017;52(1):67-69
No abstract available.
Exons*
;
Thromboembolism*
4.Reference ranges for D-dimer levels in Malaysian women in the three trimesters of pregnancy
The Malaysian Journal of Pathology 2019;41(1):7-13
Introduction: Plasma D-dimer levels rise progressively during pregnancy, so one cannot apply normal reference ranges, or the usual cut-off value (500ng/mL), for the exclusion of venous thromboembolism (VTE), in pregnant women. This study was carried out in pregnant Malaysian women in order to build applicable reference ranges for D-dimer. Materials and Methods: A cross-sectional study was conducted to measure D-dimer in healthy pregnant women, and a non-pregnant control group, using the quantitative HaemosIL D-dimer HS500 assay. Reference ranges were derived using CLSI ‘Robust’ methods, and differences between group medians were tested using the Kruskal-Wallis and Mann-Whitney U tests. Results: Plasma D-dimer levels were measured in 92 pregnant women (distributed across the three trimesters)and 31 control women. The medians (and reference ranges) in ng/mL were: control 265 (<799); first trimester 481 (<1070); second trimester 1073 (357–1748); 3rd trimester 1533 (771–2410). There were significant differences between the D-dimer levels of each group and each of the other groups (P<0.001). Conclusions: Reference ranges for D-dimer in pregnant Malaysian women have been establised by this study. Whether these ranges can be used to determine cut-off levels for the exclusion of VTE at different stages of pregnancy is doubtful, as the levels rise continuously through pregnancy, and some very high outlying values occur in apparently normal near-term pregnancy.
venous thromboembolism
5.Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism.
Blood Research 2014;49(2):77-79
No abstract available.
Anticoagulants*
;
Venous Thromboembolism*
6.An autopsy case of nonbacterial thrombotic endocarditis.
Sun Hee SUH ; Hae Yong LEE ; Won Kyu CHOI ; Mee Kyung NAMGOONG ; Jong Soo KIM ; Mee Yon CHO
Journal of the Korean Pediatric Society 1993;36(6):888-893
No abstract available.
Autopsy*
;
Endocarditis*
;
Thromboembolism
7.Thromboembolism syndrome associated with antiphospholipid antibodies and cardiovascular problems
Journal of Practical Medicine 2002;435(11):37-39
Antiphospholipid antibodies are increasingly investigated as a cause of arterial and venous thrombosis. These include anticardiolipin and lupus anticoagulant antibodies. The former was linked to several types of venous thrombosis, included deep venous thrombosis in upper and lower limbs, pulmonary embolism, intracranial venous and retinal venous thrombosis. Types of arterial thrombosis can be involved in coronary, carotid, cerebral or retinal arteries... Anticardiolipin antibody is found commonly in myocardial infarction, valve abnormalities and lupus erythematous.
Thromboembolism
;
Antibodies, Antiphospholipid
;
Cardiology
8.Primary pulmonary artery sarcoma.
Byung Ho CHOI ; Gee Young SUH ; Jeong Woong PARK
Korean Journal of Medicine 2009;77(3):304-305
No abstract available.
Pulmonary Artery
;
Sarcoma
;
Thromboembolism
9.Diagnosis and Treatment of Venous Thromboembolism in Cancer Patients.
Korean Journal of Medicine 2013;85(5):481-484
No abstract available.
Diagnosis*
;
Humans
;
Venous Thromboembolism*
10.Diagnosis and Treatment of Venous Thromboembolism in Cancer Patients.
Korean Journal of Medicine 2013;85(5):481-484
No abstract available.
Diagnosis*
;
Humans
;
Venous Thromboembolism*